Role of Miz1 in the Atr/Chk1 signalling pathway and in Myc-induced apoptosis
Role of Miz1 in the Atr/Chk1 signalling pathway and in Myc-induced apoptosis
批准号:
5422428
负责人:
Professor Dr. Martin Eilers
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Units
财政年份:
2004
资助国家:
德国
项目状态:
已结题
起止时间:
2003-12-31 至 2010-12-31
中文摘要
原癌基因c-myc在多种人类肿瘤的发生中起着关键作用。了解c-myc在肿瘤发生中的作用需要了解其生物化学和Myc影响细胞生理的蛋白质/蛋白质相互作用。c-myc编码一种转录因子(Myc),它可以激活和抑制转录。Myc与伴侣蛋白Max的异二聚体复合体介导Myc的转录激活。Myc的抑制是由不同的蛋白质复合物介导的;最具特征的是一种三聚体蛋白复合物,包含Myc、Max和锌指蛋白Miz1。我们不了解Myc如何激活和抑制转录的机制。我们最近获得的证据表明,Myc的两个已知的辅助因子,六聚体atp酶Tip48和Tip49,通过Myc和Miz1抑制转录。我们建议遵循这些发现提供的机械线索。其次,我们最近对Myc转录激活的研究已经确定了特定的激活途径,并为介质和p-TEFB复合物在Myc介导的基因激活中的功能作用提供了证据。因此,我们建议确定潜在的生化相互作用,并测试它们在激活和抑制中的作用。
英文摘要
The proto-oncogene c-myc plays a key role in the genesis of a wide variety of human tumours. Understanding how c-myc acts in tumorigenesis requires an understanding of its biochemistry and the protein/protein interactions through which Myc affects cell physiology. c-myc encodes a transcription factor (Myc) that can both activate and repress transcription. A heterodimeric complex of Myc with a partner protein, Max, mediates transcriptional activation by Myc. Repression by Myc is mediated by distinct protein complexes; the best characterized is a trimeric protein complex, which contains Myc, Max, and the zinc finger protein Miz1. We do not understand mechanistically how Myc can both activate and repress transcription. We have recently obtained evidence that two known co-factors of Myc, the hexameric ATPases Tip48 and Tip49, repress transcription through Myc and Miz1. We propose to follow the mechanistic clues provided by these findings. Second, our recent work on transcriptional activation by Myc has defined specific pathways of activation and has provided evidence for a functional role of mediator and p-TEFB complexes in Myc-mediat ed gene activation. We therefore propose to identify the underlying biochemical interactions and test their role in activation and repression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting MYC-driven hepatocellular carcinoma via Aurora-A ligands
-
批准号:409494652
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
ShRNA Screening and Histopathology
-
批准号:280454646
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Targeting MYC in pancreatic cancer
-
批准号:280452953
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Systematic shRNA screens for the analysis of critical signaling pathways in KRAS-mutant multiple myeloma
-
批准号:242271643
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Myc-dependent apoptosis as a tumor-suppressive mechanism: how do cells discriminate between physiological and oncogenic levels of Myc expression?
-
批准号:244461114
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Systemic shRNA screens and high throughout sequencing to investigate pathway dependence in multiple myeloma
-
批准号:144856378
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Systematic shRNA and siRNA screens to investigate drug resistance in human leukemia
-
批准号:81569355
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Rolle des Zink-Finger-Proteins Miz-1 in der Tumorigenese und in der Kontrolle der Proliferation von Keratinozyten und Lymphozyten
-
批准号:5340710
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2001
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Regulation of the cdk inhibitor, p27 Regulation des cdk inhibitor, p27
-
批准号:5224632
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:1995
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
MYCN-dependent Transcription Termination and Stress Resilience of Transcription
-
批准号:438596161
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Multimerization of MYC proteins as oncogenic principle
-
批准号:521472328
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Miz1在NASH相关肝癌中促进AhR/NF-κB通路失活和CD8+TRM驻留影响抗PD-1疗效的研究
-
批准号:82371850
-
项目类别:面上项目
-
资助金额:46万元
-
批准年份:2023
-
负责人:张文杰
-
依托单位:
Miz1在非酒精性脂肪性肝炎中调控肝细胞线粒体自噬及巨噬细胞炎症Cross-talk的机制研究
-
批准号:82171737
-
项目类别:面上项目
-
资助金额:57万元
-
批准年份:2021
-
负责人:张文杰
-
依托单位:
Miz1介导NF-kB通路激活调控巨噬细胞相关爆发性肝炎的机制研究
-
批准号:82101850
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘洋
-
依托单位:
Miz1介导的线粒体自噬对肝癌免疫治疗反应性影响的机制研究
-
批准号:81930086
-
项目类别:重点项目
-
资助金额:297.0万元
-
批准年份:2019
-
负责人:孙倍成
-
依托单位:
Miz1在肝脏炎癌转化中的作用及机制研究
-
批准号:81702344
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:张文杰
-
依托单位:
核糖体蛋白RPL23通过Miz1/c-Myc分子途径参与骨髓增生异常综合征发病的机制研究
-
批准号:81200346
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:吴凌云
-
依托单位: